First report 2h ago•Last update 2h ago
Swedish Trial of Psilocybin for Depression Shows Rapid, Lasting Antidepressant Effects
A Swedish clinical trial found that a 25mg dose of psilocybin rapidly reduced depression symptoms, with significant remission rates at 42 days, though long-term clinician-rated effects diminished.
Background
Research into psychedelic compounds for mental health treatment is expanding globally, with clinical trials exploring substances like psilocybin for various conditions. This trend reflects a growing interest in alternative therapies and a re-evaluation of previously restricted substances by the scientific and medical communities.
Quorum · collective opinions
Swedish Trial of Psilocybin for Depression Shows Rapid, Lasting Antidepressant Effects
First report 14h agoLast update 14h ago1 takes▲ 1
positive trial resultspositiveShow 1 post
started 14h ago•Last update 14h ago
The trial showed significant positive outcomes for psilocybin as a depression treatment, with rapid and sustained self-reported effects.
iWitness comments
No comments yet — be the first to weigh in.